🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/04/2012 | 8,80 | 8,85 | 8,53 | 8,63 | -2,40% | 3,62% | 107.080 |
| 17/04/2012 | 8,67 | 8,95 | 8,67 | 8,85 | +3,20% | 3,31% | 137.537 |
| 16/04/2012 | 8,86 | 8,88 | 8,54 | 8,57 | -2,90% | 3,80% | 156.773 |
| 13/04/2012 | 9,13 | 9,13 | 8,83 | 8,83 | -3,48% | 3,35% | 149.400 |
| 12/04/2012 | 9,26 | 9,33 | 9,06 | 9,15 | -1,41% | 2,83% | 116.378 |
| 11/04/2012 | 9,20 | 9,43 | 9,18 | 9,28 | +1,71% | 2,71% | 116.378 |
| 10/04/2012 | 9,18 | 9,46 | 9,05 | 9,12 | -4,13% | 4,55% | 334.546 |
| 09/04/2012 | 9,59 | 9,59 | 9,41 | 9,51 | -2,31% | 1,89% | 193.001 |
| 05/04/2012 | 9,66 | 9,80 | 9,55 | 9,74 | +0,52% | 2,58% | 90.089 |
| 04/04/2012 | 9,99 | 10,12 | 9,05 | 9,69 | -4,72% | 10,81% | 666.367 |
| 03/04/2012 | 10,39 | 10,39 | 10,07 | 10,17 | -2,22% | 3,06% | 122.149 |
| 02/04/2012 | 9,95 | 10,47 | 9,92 | 10,40 | +4,51% | 5,58% | 291.265 |
| 30/03/2012 | 10,70 | 10,70 | 9,94 | 9,95 | -6,67% | 7,17% | 444.993 |
| 29/03/2012 | 10,84 | 10,90 | 10,64 | 10,66 | -2,29% | 2,42% | 159.659 |
| 28/03/2012 | 11,19 | 11,24 | 10,87 | 10,91 | -2,29% | 3,29% | 131.767 |
| 27/03/2012 | 11,35 | 11,47 | 11,16 | 11,17 | -1,86% | 2,69% | 93.295 |
| 26/03/2012 | 11,39 | 11,69 | 11,29 | 11,38 | +1,05% | 3,51% | 193.162 |
| 23/03/2012 | 11,12 | 11,27 | 10,97 | 11,26 | +1,12% | 2,69% | 90.089 |
| 22/03/2012 | 10,99 | 11,14 | 10,92 | 11,14 | +0,79% | 2,04% | 109.004 |
| 21/03/2012 | 11,27 | 11,29 | 10,99 | 11,05 | -1,88% | 2,71% | 214.962 |
| 20/03/2012 | 11,17 | 11,37 | 10,94 | 11,26 | +0,56% | 3,85% | 198.772 |
| 19/03/2012 | 10,16 | 11,35 | 10,16 | 11,20 | +10,19% | 11,79% | 532.036 |
| 16/03/2012 | 10,12 | 10,32 | 10,11 | 10,16 | +0,12% | 2,10% | 145.392 |
| 15/03/2012 | 10,11 | 10,17 | 10,06 | 10,15 | +0,81% | 1,05% | 94.256 |
| 14/03/2012 | 10,11 | 10,24 | 10,03 | 10,07 | -0,62% | 2,10% | 159.979 |
| 13/03/2012 | 10,01 | 10,21 | 9,93 | 10,13 | +1,75% | 2,87% | 244.778 |
| 12/03/2012 | 9,84 | 9,99 | 9,71 | 9,96 | +1,01% | 2,92% | 416.139 |
| 09/03/2012 | 9,86 | 9,94 | 9,79 | 9,86 | -0,13% | 1,52% | 113.973 |
| 08/03/2012 | 9,88 | 9,94 | 9,78 | 9,87 | +0,76% | 1,71% | 90.089 |
| 07/03/2012 | 9,56 | 9,87 | 9,51 | 9,79 | +2,88% | 3,78% | 163.025 |